Provide strategic, technical, and operational leadership for clinical interpretation and reporting activities across core technologies including whole genome sequencing (WGS), whole exome sequencing (WES), targeted NGS panels, and chromosomal microarray (CMA)
Serve as a subject matter expert in genomic testing workflows, interpretation frameworks, and clinical reporting standards, ensuring scientific rigor, clinical relevance, and regulatory compliance
Oversee day-to-day operational performance, including production scheduling, capacity planning, process health monitoring, and escalation of operational incidents
Establish, optimize, and scale end-to-end workflows for clinical interpretation and reporting, applying continuous improvement methodologies to improve efficiency, quality, and throughput
Define, implement, and monitor key operational metrics to assess performance, identify risk, and communicate status, trends, and opportunities to senior leadership
Ensure delivery of high-quality clinical reports that meet established turnaround time, accuracy, and quality benchmarks
Lead diagnosis and resolution of complex production issues, driving root-cause analysis and implementation of sustainable corrective and preventive actions
Develop and execute operational strategies and goals aligned with broader organizational objectives and key results
Act as an individual-contributor Director with significant strategic and operational scope, with the expectation of evolving people leadership responsibilities as the organization scales
Mentor and coach scientists, genetic counselors, and operational partners, fostering a culture of continuous learning, accountability, and scientific excellence
Collaborate cross-functionally with Laboratory, Bioinformatics, Product, Quality, Regulatory, IT, and Clinical Development teams to support successful launch of new assays, tools, and initiatives
Provide input into strategic planning, organizational design, and capacity modeling through data-driven insights
Foster a culture of operational excellence, best practices, and professional growth
Perform other duties as assigned in support of departmental and company goals
Requirements
PhD in Biological Sciences, Molecular Genetics, Human Genetics, or a related field, with a minimum of 5 years of related work experience; or Master’s degree in Genetic Counseling, Biological Sciences, Molecular Genetics, Human Genetics, or a related field, with a minimum of 6 years of related work experience; or Bachelor’s degree in Genetics, Biological Sciences, Molecular Genetics, Human Genetics, or a related field, with a minimum of 7 years of related work experience
Clinical genomics or molecular diagnostics experience in a CLIA-certified or similarly regulated laboratory environment
Variant interpretation, curation, and clinical reporting for NGS-based assays, including WGS, WES, and/or targeted panels
Operational leadership supporting clinical interpretation or reporting workflows, including capacity planning, quality management, and process optimization
Cross-functional collaboration with laboratory, bioinformatics, product, quality, regulatory, or clinical development teams
Experience supporting the development, launch, or scaling of clinical genomic assays or interpretation programs
Minimum of 5 years of experience in operational leadership, including workflow optimization, capacity planning, performance metrics, and cross-functional execution
Strong understanding of clinical reporting operations, quality systems, and regulated laboratory environments (e.g., CLIA, CAP)
Proven ability to operate at a Director level, balancing strategic planning with hands-on operational leadership
Strong analytical, problem-solving, and communication skills, with the ability to translate technical and operational data into executive-level insights
Demonstrated technical expertise with whole genome sequencing (WGS) and whole exome sequencing (WES), including strong understanding of clinical interpretation frameworks, reporting standards, and end-to-end workflows
Knowledge of advanced copy number detection methodologies and copy number variant (CNV) interpretation across CMA and NGS-based platforms